Friday, 7 August 2026, 22:01
Louisiana lawmakers moved to restrict abortion access by making abortion pills harder to get. But the law has also made a common emergency treatment slower, and doctors warn that lives are at stake.
Misoprostol is a cheap, shelf-stable drug used to stop heavy bleeding after childbirth. It also plays a role in medication abortion as part of a two-pill regimen with mifepristone. Because of that second use, Louisiana lawmakers classified misoprostol as a controlled substance in 2024.
Previously, hospital hemorrhage carts included misoprostol so doctors could grab it instantly. Now the drug must be stored in a locked secure room, meaning a nurse has to leave the patient to fetch it.
Dr. Nicole Freehill, an OB-GYN in New Orleans, described the impact to KFF Health News: "You could literally have someone lose, like, a liter of blood or more in that time frame." She noted that alternative drugs may not be safe for patients with asthma or high blood pressure and are more expensive.
Dr. Freehill's preliminary research found that hemorrhage rates have worsened statewide since the law took effect. She says the reclassification has undercut years of progress aimed at reducing postpartum hemorrhage and blood transfusions.
After Roe v. Wade was overturned in 2022, Louisiana adopted a near-total abortion ban. The number of procedures performed in the state fell from 7,444 in 2021 to fewer than five in 2024. But that did not stop residents from seeking abortion outside the formal system.
The Society of Family Planning counted more than 7,500 Louisianans who used medication abortion in 2024. Many obtained pills through telehealth appointments and mail delivery, despite the ban. This trend is also visible nationally, with total abortion numbers largely stable since 2022.
Louisiana has tried to stop telehealth abortion prescriptions with a lawsuit against the FDA. The case is now before the U.S. Supreme Court. State policy experts say restrictive states are increasing liability threats to providers who prescribe pills from states with shield laws.
Although the law applies only in Louisiana, the legal fight over mifepristone and misoprostol could affect patients in every state, including California. If the Supreme Court restricts mifepristone, telehealth abortion access could narrow even in states that protect reproductive rights.
California has generally taken the opposite approach from Louisiana by expanding abortion access and protecting clinicians.
The Louisiana bill was introduced by state Rep. Thomas Pressly after his brother-in-law gave his sister abortion pills without her knowledge. The failed attempt ended with the baby born and the husband sentenced to six months in prison. The legislature then expanded the bill to add strict controls on both mifepristone and misoprostol.
The New Orleans Health Department has called for repeal, warning that the law harms patients.
Louisiana's misoprostol law shows how restrictions designed for one purpose can spill into routine medical care. Doctors say the added delay in treating hemorrhage could undo decades of safety improvements. With a Supreme Court case pending, the outcome may determine whether abortion pills stay accessible nationwide.
